Showing results (41-50 of 277) with videos related to
Sort By:
Pageof 28
Frontiers in Aging Neuroscience|August 1, 2022
Apolipoprotein E Genotype e2: Neuroprotection and Its LimitsHyun Kim, Davangere P Devanand, Scott Carlson, et al.The Journal of Clinical Psychiatry|February 1, 1988
The development of mania and organic euphoria during ECTD P Devanand, H A Sackeim, P Decina, et al.Current Opinion in Neurology|February 17, 2022
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trialsScott Carlson, Hyun Kim, Davangere P Devanand, et al.Journal of Geriatric Psychiatry and Neurology|September 12, 2003
Pica in the geriatric mentally ill: unrelenting and potentially fatalNoel I Dumaguing, Indra Singh, Mohammad Sethi, et al.Convulsive Therapy|December 1, 1995
Subjective side effects during electroconvulsive therapyD P Devanand, L Fitzsimons, J Prudic, et al.The American Journal of Psychiatry|July 1, 1991
Absence of cognitive impairment after more than 100 lifetime ECT treatmentsD P Devanand, A K Verma, F Tirumalasetti, et al.JAMA Psychiatry|February 16, 2022
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related DementiasDavangere P Devanand, Seonjoo Lee, Edward D Huey, et al.Archives of Neurology|August 1, 1989
A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's diseaseD P Devanand, H A Sackeim, R P Brown, et al.Behavioural Brain Research|December 28, 2020
Odorant-induced brain activation as a function of normal aging and Alzheimer's disease: A preliminary studyJason Steffener, Jeffrey N Motter, Matthias H Tabert, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2023
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trialsTerry E Goldberg, Seonjoo Lee, Davangere P Devanand, et al.Pageof 28